Betterlife Pharma Inc (BETR.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 01/31
(Values in thousands)
| 07-2025 | 04-2025 | 01-2025 | 10-2024 | 07-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 22 | 19 | 8 | 19 | 126 |
| Receivables | 9 | 8 | 12 | 7 | 25 |
| Other current assets | 198 | 205 | 205 | 245 | 298 |
| TOTAL | $229 | $232 | $225 | $271 | $450 |
| Non-Current Assets | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $229 | $232 | $225 | $271 | $450 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 590 | 870 | 871 | 48 | 29 |
| Accounts payable and accrued liabilities | 3,855 | 3,912 | 4,495 | 4,301 | 4,765 |
| Other current liabilities | 216 | 282 | 313 | 20 | 32 |
| TOTAL | $5,987 | $6,264 | $7,538 | $5,871 | $6,259 |
| Non-Current Liabilities | |||||
| Long Term Debt | 54 | 51 | 49 | 809 | 774 |
| Other Non-Current Liabilities | -3,310 | -3,320 | -3,315 | -3,110 | -2,908 |
| TOTAL | $54 | $51 | $49 | $1,046 | $1,763 |
| Total Liabilities | $6,040 | $6,316 | $7,587 | $6,917 | $8,022 |
| Shareholders' Equity | |||||
| Common Shares | 81,958 | 81,397 | 79,965 | 79,815 | 79,821 |
| Retained earnings | -119,302 | -118,807 | -118,596 | -117,860 | -118,462 |
| Other shareholders' equity | 28,222 | 28,007 | 27,953 | 28,054 | 27,763 |
| TOTAL | $-9,121 | $-9,403 | $-10,678 | $-9,992 | $-10,878 |
| Total Liabilities And Equity | $-3,081 | $-3,088 | $-3,090 | $-3,075 | $-2,856 |